Table 3 Changes in body composition, metabolic and cardiovascular risk factors (intention-to-treat analysis)
Variable1 | DGE group (n = 100)2 | LOGI group (n = 100)2 | P value3 |
|---|---|---|---|
Fat mass (kg) | |||
6 months | -4.6 (3.7)4 | -5.6 (4.2)4 | 0.073 |
12 months | -3.3 (4.4)4 | -4.2 (4.9)4 | 0.132 |
Fat free mass (kg) | |||
6 months | -1.6 (2.1)4 | -1.6 (2.5)4 | 0.740 |
12 months | -1.3 (3.6)4 | -1.5 (2.5)4 | 0.794 |
BMI (kg/m2) | |||
6 months | -2.1 (1.6)4 | -2.3 (1.8)4 | 0.250 |
12 months | -1.5 (1.8)4 | -1.9 (2.1)4 | 0.110 |
Waist circumference (cm) | |||
6 months | -6.6 (5.3)4 | -8.0 (5.5)4 | 0.083 |
12 months | -4.7 (8.9)4 | -6.9 (6.1)4 | 0.037 |
Systolic blood pressure (mmHg) | |||
6 months | -4 (15)4 | -6 (16)4 | 0.102 |
12 months | -1 (15) | -5 (14)4 | 0.007 |
Diastolic blood pressure (mmHg) | |||
6 months | -3 (9)4 | -3 (8)4 | 0.884 |
12 months | -2 (8)4 | -3 (9)4 | 0.440 |
Triglyceride (mmol/l) | |||
6 months | -0.03 (0.55) | -0.18 (0.40)4 | 0.005 |
12 months | -0.04 (0.50) | -0.10 (0.47)4 | 0.164 |
Total cholesterol (mmol/l) | |||
6 months | -0.07 (0.50) | -0.07 (0.56) | 0.926 |
12 months | 0.13 (0.61)4 | 0.03 (0.75) | 0.259 |
LDL-cholesterol (mmol/l) | |||
6 months | -0.03 (0.51) | -0.03 (0.50) | 0.921 |
12 months | 0.06 (0.59) | 0.02 (0.65) | 0.564 |
HDL-cholesterol (mmol/l) | |||
6 months | -0.09 (0.19)4 | -0.02 (0.20) | 0.005 |
12 months | -0.03 (0.17) | -0.02 (0.21) | 0.668 |
Glucose (mmol/l) | |||
6 months | -0.28 (0.59)4 | -0.26 (0.76)4 | 0.475 |
12 months | -0.14 (0.46)4 | -0.25 (0.75)4 | 0.235 |
HbA1c (%) | |||
6 months | -0.2 (0.2)4 | -0.2 (0.2)4 | 0.840 |
12 months | -0.2 (0.2)4 | -0.2 (0.2)4 | 0.314 |
Fructosamine (μmol/L) | |||
6 months | -0.4 (27.5) | 1.1 (24.6) | 0.960 |
12 months | -5.9 (24.6)4 | -8.8 (31.1)4 | 0.580 |
Proinsulin (pmol/L) | |||
6 months | -1.4 (11.4) | -3.7 (14.8) | 0.676 |
12 months | -2.2 (8.2)4 | -5.0 (14.0)4 | 0.148 |
Adiponectin (μg/ml) | |||
6 months | -0.2 (3.4) | -0.1 (3.0) | 0.929 |
12 months | 0.9 (2.7)4 | 1.3 (2.6)4 | 0.288 |